CARPL.ai, the world's largest radiology AI marketplace and enterprise platform, has raised aSeries A round of USD 10 millionled byInternational Finance Corporation (IFC), the private sector arm of the World Bank Group, with participation fromStellaris Venture Partnersand other investors. The funding will accelerate CARPL’s mission to help healthcare providers adopt AI in a meaningful and safe manner. CARPL is trusted by the world’s largest and most prestigious healthcare organisations, includingfour of the world’s top five private radiology groups. It is also being used by many governments, includingBrazil,India,Singapore,SpainandtheUAE. Medical imaging generates more than 80% of healthcare data, as imaging demand continues to outpace radiologist capacity. Although more than 1,000 FDA-cleared radiology AI applications are available today, adoption remains fragmented. Healthcare organisations are forced to evaluate, integrate, and monitor dozens of standalone AI products independently, creating significant operational and IT complexity. In short, while the AI applications exist, the governance of these applications does not. Through a single integration with CARPL, healthcare providers gain access to the world's largest radiology AI marketplace with more than 300 AI applications from over 100 partners. In addition to this, the CARPL platform also enables its customers to build, test, deploy, and monitor AI across clinical workflows while remaining vendor-neutral and infrastructure-agnostic. The investment will support continued product innovation,expansion of CARPL's global partner ecosystem, and commercial growth acrossNorth America,LATAM,Europe,Asia-Pacific, and emerging markets. The partnership also reflects a shared focus on advancing digital health innovation through CARPL’s model of building high-skill engineering, product development, and AI capabilities in India for deployment to healthcare providers around the world. While CARPL has started in the domain of radiology, which has 1000s of AI applications waiting to be deployed, the goal is to become the integration, utilisation, and procurement layer for all clinical AI that goes into healthcare organisations.“We will soon move beyond medical imaging into the domains of pathology, genomics and general medicine, and one day, if there is a robotic surgeon somewhere using AI to perform surgery, we hope that it will be running through CARPL,” Dr Mahajan added.
